Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
University Hospital, Monterrey, Mexico.
Sodium valproate (VA) and clonazepam (CLZ) were combined in the treatment of 4 patients with panic disorders (PD) who were resistant to several antipanic drug treatments. A significant improvement was found in the symptomatology of these patients, but relapses occurred when CLZ dosage was reduced. A potentiation of the GABAergic properties of VA and clonazepam is postulated. This combined treatment could be advantageous for some treatment-resistant PD patients but needs to be studied further.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on